What is the maximum allowed dose of Fludicate (fluphenazine decanoate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION: ... Dosage should not exceed 100 mg. If doses greater than 50 mg are deemed necessary, the next dose and succeeding doses should be increased cautiously in increments of 12. 5 mg. The maximum allowed dose of Fludicate (fluphenazine decanoate) is 100 mg 1.

From the Research

The maximum allowed dose of fluphenazine decanoate (Fludicate) should not exceed 100 mg every 2-3 weeks, with typical maintenance dosing ranging from 12.5 to 50 mg administered intramuscularly every 2-4 weeks, as higher doses increase the risk of extrapyramidal symptoms, including tardive dyskinesia, akathisia, and parkinsonism 2. When initiating treatment, it's recommended to start with a lower test dose (12.5-25 mg) to assess tolerability before increasing to therapeutic levels.

  • Fluphenazine decanoate is a long-acting antipsychotic medication used primarily for schizophrenia and other psychotic disorders.
  • The medication is administered as a deep intramuscular injection, preferably in the gluteal muscle.
  • Dosing should be individualized based on the patient's clinical response and side effect profile.
  • Regular monitoring for extrapyramidal symptoms is essential, and anticholinergic medications should be available to manage acute dystonic reactions 3, 4.
  • Studies have shown that lower doses of fluphenazine decanoate may be effective in preventing psychotic relapse while minimizing total cumulative dosage 5.
  • However, the relationship between fluphenazine dosage and acute outcome is complex, and higher doses may be associated with greater clinical improvement but also with a higher incidence of extrapyramidal symptoms 6.
  • Therefore, the dose of fluphenazine decanoate should be carefully titrated to achieve the optimal balance between efficacy and tolerability, with a focus on minimizing the risk of extrapyramidal symptoms and other adverse effects 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.